| Literature DB >> 24960027 |
Saemee Song1, Soonhye Hwang1, Seunghwa Lee1, Nam-Chul Ha2, Kangseok Lee1.
Abstract
To survive in the presence of a wide range of toxic compounds, gram-negative bacteria expel such compounds via tripartite efflux pumps that span both the inner and outer membranes. The Salmonella-specific MdsAB pump consists of MdsB, a resistance-nodulation-division (RND)-type inner membrane transporter (IMT) that requires the membrane fusion protein (MFP) MdsA, and an outer membrane protein (OMP; MdsC or TolC) to form a tripartite efflux complex. In this study, we investigated the role of the putative tip regions of MdsA and its OMPs, MdsC and TolC, in the formation of a functional MdsAB-mediated efflux pump. Comparative analysis indicated that although sequence homologies of MdsA and MdsC with other MFPs and OMPs, respectively, are extremely low, key residues in the putative tip regions of these proteins are well conserved. Mutagenesis studies on these conserved sites demonstrated their importance for the physical and functional interactions required to form an MdsAB-mediated pump. Our studies suggest that, despite differences in the primary amino acid sequences and functions of various OMPs and MFPs, interactions mediated by the conserved tip regions of OMP and MFP are required for the formation of functional tripartite efflux pumps in gram-negative bacteria.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24960027 PMCID: PMC4069162 DOI: 10.1371/journal.pone.0100881
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Bacterial strains and plasmids used in this study.
| Strain or plasmid | Relevant characteristics | Reference |
| ATCC14028S |
|
|
|
| ΔacrAB | This study |
|
| ΔacrABΔmdsABC::CmR | This study |
|
| ΔacrABΔmdsABC::CmRΔtolC::TnR | This study |
|
| ||
| pKD3 | repR6Kγ[p] ApR FRT CmR FRT |
|
| pCP20 | reppSC101
tsAPR CmR
|
|
| pKAN6B | p15A |
|
| pACYC184 | p15A |
|
|
| ||
| pMdsAB |
| This study |
| pMdsAB2 | Same as pMdsAB, but also expresses a c-terminal flag-tagged MdsA (MdsA-c-flag) | This study |
| pMdsAB2-MdsA-R135D | Same as pMdsAB2, but expresses an MdsA R135D mutant | This study |
| pMdsAB2-MdsA-L139D | Same as pMdsAB2, but expresses an MdsA L139D mutant | This study |
| pMdsAB2-MdsA-S146D | Same as pMdsAB2, but expresses an MdsA S146D mutant | This study |
| pMdsABC2 |
| This study |
| pMdsABC2-MdsA-R135D | Same as pMdsABC2, but expresses an MdsA R135D mutant | This study |
| pMdsABC2-MdsA-L139D | Same as pMdsABC2, but expresses an MdsA L139D mutant | This study |
| pMdsABC2-MdsA-S146D | Same as pMdsABC2, but expresses an MdsA S146D mutant | This study |
| pMdsABC2-MdsC-G220A | Same as pMdsABC2, but expresses an MdsC G220A mutant | This study |
| pMdsABC2-MdsC-G433A | Same as pMdsABC2, but expresses an MdsC G433A mutant | This study |
| pMdsABC2-MdsC-L441R | Same as pMdsABC2, but expresses an MdsC L441R mutant | This study |
| pMdsC2 | Same as pMdsABC2, but with truncated parts of MdsA and MdsB | This study |
| pMdsC2-G220A | Same as pMdsC2, but expresses an MdsC G220A mutant | This study |
| pMdsC2-G433A | Same as pMdsC2, but expresses an MdsC G433A mutant | This study |
| pMdsC2-L441R | Same as pMdsC2, but expresses an MdsC L441R mutant | This study |
Figure 1Sequence comparisons of the putative tip regions of MdsA and MdsC.
(A) Sequence alignment of the RLS motifs from three distinct adapter proteins. The corresponding heptad positions are marked in bold. The three conserved residues are highlighted in the black box. (B) Conserved amino acid residues in repeat 1 and repeat 2 in the aperture tip region of OMP. Repeat sequences in the tip regions are shown in bold, and conserved residues are shown in black boxes. Se, Salmonella enterica; Ec, Escherichia coli; Pa, Pseudomonas aeruginosa; Vc, Vibrio cholerae. (C) A modeled complex structure of the α-hairpin tip regions of MdsA and MdsC structure, based on the adaptor bridging model [23]. The residues mentioned in the text are shown in the stick representations.
The in vivo effect of mutations in the conserved region of MdsAa in the presence of the wild-type MdsB and MdsC and in the absence of TolC.
| Background | ATCC14028S | |||
| MdsA protein | MIC (µg/mL) | |||
| Crystal violet | Methylene blue | Acriflavine | Rhodamine 6G | |
| None | 4 | 32 | 16 | 4 |
| MdsA-WT | 16 | 256 | 32 | 64 |
| MdsA-R135D | 4 | 32 | 16 | 4 |
| MdsA-L139D | 4 | 32 | 16 | 4 |
| MdsA-S146D | 4 | 32 | 16 | 4 |
The in vivo effect of mutations in the conserved region of MdsA was determined by measuring the resistance of the ATCC14028SΔacrABΔmdsABC::Cm5ΔtolC::Tn10 strain to several substrates. MdsA and its variants were expressed from pMdsABC2, pMdsABC2 MdsA-R135D, pMdsABC2 MdsA-L139D, and pMdsABC2 MdsA-S146D.
All MIC measurements were done in triplicate. The concentrations of crystal violet and acriflavine used to determine the MICs were 0, 1, 2, 4, 8, 16, and 32 µg/mL. The concentrations of rhodamine 6G and methylene blue used to determine the MICs were 0, 4, 8, 16, 32, 64, 128, and 256 µg/mL.
None, strain carrying the empty vector pKAN6B instead of a pMdsABC2 variant.
Figure 2Physical interaction between MdsA or MdsA variants and MdsC in vivo.
(A) Protein expression of Flag-tagged MdsA and MdsA variants (MdsA-R135D, MdsA-L139D, and MdsA-S146D), MdsB-Myc, and hexahistidine-tagged MdsC was detected by western blotting. (B) The in vivo interaction between MdsA and MdsC was analyzed by using the chemical-crosslinker DSP. S. enterica ATCC14028SΔacrABΔmdsABC::Cm5ΔtolC::Tn10 cells coexpressing c-flag-tagged wild-type (WT) or mutant MdsA (R135D, L139D, and S146D), c-myc-tagged MdsB, hexahistidine-tagged MdsC were tested. All cultures were treated with (+) or without (−) DSP. Affinity-purified MdsC and crosslinked MdsA and MdsA variants were separated by SDS-PAGE and immunoblotted using monoclonal anti-His-tag and anti-Flag-tag antibodies.
The in vivo effect of mutations in the conserved region of MdsAa in the presence of wild-type MdsB and TolC without MdsC.
| Background | ATCC14028S | |||
| MdsA protein | MIC (µg/mL) | |||
| Crystal violet | Methylene blue | Acriflavine | Rhodamine 6G | |
| None | 4 | 32 | 16 | 4 |
| MdsA-WT | 16 | 256 | 32 | 64 |
| MdsA-R135D | 8 | 64 | 16 | 32 |
| MdsA-L139D | 4 | 32 | 16 | 8 |
| MdsA-S146D | 16 | 256 | 32 | 64 |
The in vivo effect of each mutation in the conserved region of MdsA was determined by measuring the resistance of the ATCC14028SΔacrABΔmdsABC::Cm5 strain to several substrates. MdsA and its variants were expressed from pMdsAB2, pMdsAB2 MdsA-R135D, pMdsAB2 MdsA-L139D, and pMdsAB2 MdsA-S146D.
All MIC measurements were done in triplicate. The concentrations of crystal violet and acriflavine used to determine the MICs were 0, 1, 2, 4, 8, 16, and 32 µg/mL. The concentrations of rhodamine 6G and methylene blue used to determine the MICs were 0, 4, 8, 16, 32, 64, 128, and 256 µg/mL.
None, strain carrying the empty vector pKAN6B instead of an pMdsAB2 variant.
The in vivo effect of mutations at the aperture tip region of MdsCa in the presence of wild type MdsA and MdsBa.
| Background | ATCC14028S | ||||
| MdsC protein | MIC (µg/mL) | ||||
| Crystal violet | Methylene blue | Acriflavine | Rhodamine 6G | Vancomycin | |
| None | 4 | 32 | 16 | 4 | 800 |
| MdsC-WT | 16 | 256 | 32 | 64 | 700 |
| MdsC-G220A | 4 | 32 | 16 | 4 | 500 |
| MdsC-G433A | 4 | 32 | 16 | 4 | 600 |
| MdsC-L441R | 4 | 32 | 16 | 4 | 700 |
The in vivo effect of mutations in the aperture tip region of MdsC was determined by measuring the resistance of the ATCC14028SΔacrABΔmdsABC::Cm5ΔtolC::Tn10 strain to several substrates. MdsC and its variants were expressed from pMdsABC2, pMdsABC2 MdsC-G220A, pMdsABC2 MdsC-G433A, pMdsABC2 MdsC-L441R.
All MIC measurements were done in triplicate. The concentrations of crystal violet and acriflavine used to determine the MICs were 0, 1, 2, 4, 8, 16, and 32 µg/mL. The concentrations of rhodamine 6G and methylene blue used to determine the MICs were 0, 4, 8, 16, 32, 64, 128, and 256 µg/mL.
The vancomycin concentrations used to determine the MICs were 0, 300, 400, 500, 600, 700, and 800 µg/mL.
None, strain carrying the empty vector pKAN6B instead of a pMdsABC2 variant.
Figure 3Interaction between MdsC or MdsC variants and MdsA in vivo.
(A) Protein expression of hexahistidine-tagged MdsC and MdsC variants (MdsC-G220A, MdsC-G433A, and MdsC-L441R), MdsA-Flag and MdsB-Myc was detected by western blotting. (B) The in vivo interaction between MdsA and MdsC or MdsC variants was detected by using the chemical-crosslinker DSP. S. enterica ATCC14028SΔacrABΔmdsABC::Cm5ΔtolC::Tn10 cells coexpressing c-Flag-tagged MdsA, c-Myc-tagged MdsB, and hexahistidine-tagged wild-type (WT) or mutant MdsC (G220A, G433A, and L441R) are shown. All cultures were treated with (+) or without (−) DSP. Affinity-purified MdsC or MdsC variants and crosslinked MdsA were separated by SDS-PAGE and immunoblotted using monoclonal anti-His-tag and anti-Flag-tag antibodies.
The in vivo effect of mutations at the aperture tip region of MdsC in the absence of functional MdsA, MdsB, and TolCa.
| Background | ATCC14028S | ||||
| MdsC protein having no functional MdsA-MdsB | MIC (µg/mL) | ||||
| Crystal violet | Methylene blue | Acriflavine | Rhodamine 6G | Vancomycin | |
| MdsC-WT | 4 | 32 | 16 | 4 | 800 |
| MdsC-G220A | 4 | 32 | 16 | 4 | 800 |
| MdsC-G433A | 4 | 32 | 16 | 4 | 800 |
| MdsC-L441R | 4 | 32 | 16 | 4 | 800 |
The in vivo effect of mutations in the aperture tip region of MdsC when wild-type MdsA and MdsB were disrupted was determined by measuring the resistance of the ATCC14028SΔacrABΔmdsABC::Cm5ΔtolC::Tn10 strain to several substrates. MdsC and its variants were expressed from pMdsC2, pMdsC2-G220A, pMdsC2-G433A, and pMdsC2-L441R.
All MIC measurements were done in triplicate. The concentrations of crystal violet and acriflavine used to determine the MICs were 0, 1, 2, 4, 8, 16, and 32 µg/mL. The concentrations of rhodamine 6G and methylene blue used to determine the MICs were 0, 4, 8, 16, 32, 64, 128, and 256 µg/mL. The vancomycin concentrations used to determine the MICs were 0, 300, 400, 500, 600, 700, and 800 µg/mL.